|
Market Closed -
Nasdaq
16:00:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 8.030 USD | +2.16% |
|
-1.95% | +11.37% |
| Market Cap | 243M 212M 200M 182M 340M 23.31B 342M 2.4B 925M 11.85B 913M 892M 38.14B | P/E 2026 * |
-2.68x | P/E 2027 * | -1.93x |
|---|---|---|---|---|---|
| Enterprise Value | 102M 88.9M 83.94M 76.23M 143M 9.78B 143M 1.01B 388M 4.97B 383M 374M 16B | EV / Sales 2026 * |
243x | EV / Sales 2027 * | -164x |
| Free-Float |
47.87% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RNAC | Delayed | |
CBOE
| RNAC | Real-time | |
|
Deutsche Boerse AG
| 1S70 | Delayed | |
|
Boerse Muenchen
| 1S70 | Real-time |
Last Transcript: Cartesian Therapeutics, Inc.
| 1 day | +2.16% | ||
| 1 week | -1.95% | ||
| Current month | -13.47% | ||
| 1 month | -12.72% | ||
| 3 months | -16.61% | ||
| 6 months | +20.75% | ||
| Current year | +11.37% |
| 1 week | 7.66 |  | 8.27 |
| 1 month | 7.66 | | 10.88 |
| Current year | 5.6 | | 11 |
| 1 year | 5.6 | | 11 |
| 3 years | 5.6 | | 42.6 |
| 5 years | 5.6 | | 42.6 |
| 10 years | 5.6 | | 42.6 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/2/26 | Exercice | 758,001 | 2.8594% | |||
| 4/2/26 | Exercice | 22,740 | - | - | ||
| 4/2/26 | Exercice | 22,740 | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.16% | -1.95% | -22.11% | - | 238M | |
| -0.31% | +5.79% | +48.93% | +97.53% | 70.89B | |
| +0.39% | +2.06% | +40.91% | +78.49% | 62.32B | |
| -3.21% | -7.27% | -17.73% | +351.98% | 27.07B | |
| -2.64% | -0.69% | -0.26% | -11.90% | 24.78B | |
| +0.71% | +8.03% | +27.22% | -13.18% | 20.59B | |
| -1.26% | -7.81% | +169.33% | +302.38% | 15.52B | |
| -0.22% | +3.99% | +44.28% | +173.35% | 14.49B | |
| +0.73% | +1.71% | -7.18% | +886.19% | 14.14B | |
| -0.54% | -0.56% | +20.59% | +224.93% | 12.35B | |
| Average | -0.42% | +0.79% | +30.40% | +232.20% | 26.24B | |
| Weighted average by Cap. | -0.59% | +1.00% | +36.24% | +165.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 419K 365K 345K 313K 587K 40.22M 590K 4.13M 1.6M 20.45M 1.57M 1.54M 65.79M | 286K 249K 235K 214K 400K 27.42M 402K 2.82M 1.09M 13.94M 1.07M 1.05M 44.85M |
| Net income | -88.12M -76.84M -72.56M -65.89M -123M -8.46B -124M -869M -335M -4.3B -331M -324M -13.83B | -144M -126M -119M -108M -202M -13.82B -203M -1.42B -548M -7.03B -541M -529M -22.61B |
| Net Debt | -141M -123M -116M -105M -198M -13.53B -198M -1.39B -537M -6.88B -530M -518M -22.13B | -290M -253M -239M -217M -406M -27.8B -408M -2.86B -1.1B -14.13B -1.09B -1.06B -45.47B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | US$8.030 | +2.16% | 211,660 |
| 26-09-17 | US$7.860 | -0.63% | 164,460 |
| 26-09-16 | US$7.910 | +0.25% | 117,997 |
| 26-09-15 | US$7.890 | -1.87% | 113,269 |
| 26-09-14 | US$8.040 | -1.83% | 110,247 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RNAC Stock
Select your edition
All financial news and data tailored to specific country editions
